Development of a Parallel Strategy for the Synthesis of a Library of 2-(3-Formyl-5-arylfuran-2-yl)ethylcarbamates from Dihydropyridinones

View/ Open
Issue Date
2008-09-09Author
Kim, An Na
Publisher
University of Kansas
Format
73 pages
Type
Thesis
Degree Level
M.S.
Discipline
Medicinal Chemistry
Rights
This item is protected by copyright and unless otherwise specified the copyright of this thesis/dissertation is held by the author.
Metadata
Show full item recordAbstract
2,3-Dihydropyridin-4(1H)-ones were utilized as scaffolds for the syntheses of libraries of 5-arylethynyl-2,3-dihydropyridin-4(1H)-ones and 2-(3-formyl-5-arylfuran-2-yl)ethylcarbamates. 2,3-Dihydropyridin-4(1H)-ones were prepared from piperidones, ynones, and pyridones and used for the synthesis of a library of 5-arylethynyl-2,3-dihydropyridin-4(1H)-ones employing a Sonogashira reaction. Further reaction of these compounds using an Au(III)-catalyzed cyclization method yielded formylfurans. N-Boc and N-benzyl protected 2,3-dihydropyridin-4(1H)-ones were prepared for the Sonogashira reaction. N-Boc-protected 5-iodo-2,3-dihydropyridin-4(1H)-ones provided tert-butyl 5-arylethynyl-4-oxo-3,4-dihydropyridine-1(2H)-carboxylates in moderate to excellent yields while the N-Bn-protected enaminones provided low yields of 5-arylethynyl-1-benzyl-2,3-dihydropyridin-4(1H)-ones. Furan formation was achieved by Au(III)-catalyzed and Cu-mediated cyclizations. (±)tert-Butyl 1-(3-formyl-5-phenylfuran-2-yl)propan-2-ylcarbamates were obtained during the Sonogashira reactions catalyzed by Cu(I), while (±)tert-Butyl 1-(3-formyl-5-phenylfuran-2-yl)-3-phenylpropan-2-ylcarbamates were formed by the Au(III)-catalyzed cyclization. A library of 16 compounds of highly substituted furans was synthesized in moderate to excellent yields.
Collections
- Medicinal Chemistry Dissertations and Theses [80]
- Theses [3906]
Items in KU ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
We want to hear from you! Please share your stories about how Open Access to this item benefits YOU.